Historical performance in the Clinical development category.
Source: Acquire.fyi, Jan 1, 2025 - Jul 13, 2026.
Largest mergers and acquisitions by disclosed deal value.
| Acquirer | Target | Type | Value | Headline |
|---|---|---|---|---|
| Novartis | Myricx Bio | Acquisition | $1.5B | Novartis Bets $1.5 Billion on Myricx ADC Payload Platform |
| AstraZeneca | Modella AI | Acquisition | Undisclosed | AstraZeneca acquires Modella AI |
| GHO Capital Partners LLP | Scientist.com | Acquisition | Undisclosed | GHO Capital Partners LLP acquires Scientist.com |
Page 1 of latest articles and deal coverage.
The deal gives Novartis a differentiated antibody drug conjugate engine as large pharma races to secure better-tolerated oncology assets before clinical validation drives prices higher.